Advanced tools are being deployed by Duke Health and others in the fight against vision loss. STORY HIGHLIGHTS Half of ...

Anchor] Macular degeneration is a disease in which vision decreases due to abnormalities in the macula, the center of the ...

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and ... times as often when patients ...

Glaucoma is a group of eye diseases that can lead to vision loss and blindness. It is caused by damage to the optic nerve, a part of the back of the eye. It can affect anyone, but some groups may ...

The global glaucoma treatment market is projected to grow from USD 5.7 billion in 2022 to USD 8.0 billion by 2033, at a CAGR ...

The good news is that, while there's no cure for glaucoma, early treatment can often stop or slow the damage from progressing, per the National Eye Institute. "The pressure in the eye can often be ...

ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced a research partnership with the John A.

Legislation under consideration in Trenton could modernize the scope of access to modern eye care in New Jersey.

Health care and tech innovation go hand in hand. From delivering steady streams of medication to speeding up treatment of ...

Background Normal tension glaucoma ... right eye was used for statistical analysis. Results In 41 right eyes, the mean pre-study IOP was 14.3 ± 3.4 mmHg while on 1.5 ± 0.8 eye drops.